| Amanda Opfer, DO | |
|
400 S Clark St, Butte, MT 59701-2328 | |
| (406) 723-2585 | |
| Not Available |
| Full Name | Amanda Opfer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 400 S Clark St, Butte, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285021469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 71926 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St James Healthcare | Butte, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group-butte Llc | 2466633102 | 80 |
News Archive
Simple steps that include the consistent use of experienced medical teams for a single type of surgery, preemptive antibiotics before the procedure, less reliance on potent opioids during recovery and urging patients to get out of bed and move around sooner can not only prevent infections, blood clots and other serious complications in people undergoing colorectal operations, but can also accelerate recovery and reduce cost of care, according to results of an ongoing program at The Johns Hopkins Hospital.
Researchers from the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy (MBI) were involved in the development of a table-top solid-state laser system that could cut brain tissue with unprecedented precision. The achievement is a result of an interdisciplinary EU project that involved partners from seven European countries.
The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
What do Moby Dick, the Salem witch trials and alien abductions all have in common? They all circle back to sleep paralysis.
› Verified 7 days ago
| Entity Name | Scl Health Medical Group-butte Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477869600 PECOS PAC ID: 2466633102 Enrollment ID: O20110301000023 |
News Archive
Simple steps that include the consistent use of experienced medical teams for a single type of surgery, preemptive antibiotics before the procedure, less reliance on potent opioids during recovery and urging patients to get out of bed and move around sooner can not only prevent infections, blood clots and other serious complications in people undergoing colorectal operations, but can also accelerate recovery and reduce cost of care, according to results of an ongoing program at The Johns Hopkins Hospital.
Researchers from the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy (MBI) were involved in the development of a table-top solid-state laser system that could cut brain tissue with unprecedented precision. The achievement is a result of an interdisciplinary EU project that involved partners from seven European countries.
The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
What do Moby Dick, the Salem witch trials and alien abductions all have in common? They all circle back to sleep paralysis.
› Verified 7 days ago
| Entity Name | Bozeman Health Big Sky Medical Center Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1588141048 PECOS PAC ID: 7315256872 Enrollment ID: O20181114003365 |
News Archive
Simple steps that include the consistent use of experienced medical teams for a single type of surgery, preemptive antibiotics before the procedure, less reliance on potent opioids during recovery and urging patients to get out of bed and move around sooner can not only prevent infections, blood clots and other serious complications in people undergoing colorectal operations, but can also accelerate recovery and reduce cost of care, according to results of an ongoing program at The Johns Hopkins Hospital.
Researchers from the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy (MBI) were involved in the development of a table-top solid-state laser system that could cut brain tissue with unprecedented precision. The achievement is a result of an interdisciplinary EU project that involved partners from seven European countries.
The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
What do Moby Dick, the Salem witch trials and alien abductions all have in common? They all circle back to sleep paralysis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Opfer, DO 400 S Clark St, Butte, MT 59701-2328 Ph: (406) 723-2585 | Amanda Opfer, DO 400 S Clark St, Butte, MT 59701-2328 Ph: (406) 723-2585 |
News Archive
Simple steps that include the consistent use of experienced medical teams for a single type of surgery, preemptive antibiotics before the procedure, less reliance on potent opioids during recovery and urging patients to get out of bed and move around sooner can not only prevent infections, blood clots and other serious complications in people undergoing colorectal operations, but can also accelerate recovery and reduce cost of care, according to results of an ongoing program at The Johns Hopkins Hospital.
Researchers from the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy (MBI) were involved in the development of a table-top solid-state laser system that could cut brain tissue with unprecedented precision. The achievement is a result of an interdisciplinary EU project that involved partners from seven European countries.
The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
What do Moby Dick, the Salem witch trials and alien abductions all have in common? They all circle back to sleep paralysis.
› Verified 7 days ago
Dr. Margaret Lee Hall, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4224 Sacramento St, Butte, MT 59701 Phone: 253-509-8828 | |
Debra Rene Lewis, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500 | |
Dr. Alan R Mayer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500 | |
Dr. William Bruce Ellis, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2500 |